Contact
Please use this form to send email to PR contact of this press release:
EyePoint Pharmaceuticals Announces $16.5 Million Monetization of ILUVIEN® Royalty with SWK Holdings Corporation
TO:
Please use this form to send email to PR contact of this press release:
EyePoint Pharmaceuticals Announces $16.5 Million Monetization of ILUVIEN® Royalty with SWK Holdings Corporation
TO: